Drug search by name

Methoxsalen Extracorporeal Solution and Sunburn

Result of checking the interaction of drug Methoxsalen Extracorporeal Solution and disease Sunburn for safety when used together.

Check result:

Methoxsalen Extracorporeal Solution <> Sunburn

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Patients presenting with a sunburn should not be treated with methoxsalen (a psoralen) and ultraviolet radiation (UVA), since it may be difficult to evaluate the response of these patients to therapy. The mild, transient erythema normally seen 24 to 48 hours after PUVA (psoralen and UVA photochemotherapy) indicates a therapeutic interaction occurring between the psoralen and UVA but may be masked by a sunburn. Patients generally should avoid sunbathing for at least 24 hours prior to methoxsalen administration and UVA exposure. The usual restrictions concerning sun exposure after treatment and the prescribed dosage should also be followed closely to avoid severe burns and other phototoxic reactions.

References:

"Product Information. Oxsoralen (methoxsalen)." ICN Pharmaceuticals Inc, Costa Mesa, CA.
"Product Information. Oxsoralen Lotion (methoxsalen topical)." ICN Pharmaceuticals, Costa Mesa, CA.

Methoxsalen Extracorporeal Solution

Generic Name: methoxsalen

Brand Name: 8-Mop, Oxsoralen-Ultra, Uvadex

Synonyms: Methoxsalen, Methoxsalen (Systemic)

What is Methoxsalen Extracorporeal Solution?